DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 969 filers reported holding DANAHER CORPORATION in Q2 2015. The put-call ratio across all filers is 0.93 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $20,746,295 | -3.5% | 83,035 | -3.6% | 0.23% | -1.7% |
| Q1 2024 | $21,508,633 | +5.8% | 86,131 | -2.0% | 0.23% | -1.3% |
| Q4 2023 | $20,331,547 | -10.8% | 87,886 | -4.3% | 0.23% | -16.7% |
| Q3 2023 | $22,786,000 | -0.5% | 91,842 | -3.7% | 0.28% | +8.1% |
| Q2 2023 | $22,896,480 | -3.0% | 95,402 | +1.8% | 0.26% | -7.5% |
| Q1 2023 | $23,613,124 | -4.8% | 93,688 | +0.2% | 0.28% | -9.1% |
| Q4 2022 | $24,813,850 | +6.1% | 93,489 | +3.2% | 0.31% | -2.2% |
| Q3 2022 | $23,388,000 | +4.7% | 90,551 | +2.7% | 0.32% | +10.5% |
| Q2 2022 | $22,344,000 | -10.2% | 88,136 | +3.9% | 0.29% | +7.9% |
| Q1 2022 | $24,889,000 | -9.8% | 84,850 | +1.1% | 0.26% | -5.4% |
| Q4 2021 | $27,604,000 | +8.9% | 83,901 | +0.7% | 0.28% | +11.6% |
| Q3 2021 | $25,359,000 | +14.2% | 83,296 | +0.7% | 0.25% | +14.6% |
| Q2 2021 | $22,198,000 | +20.7% | 82,718 | +1.2% | 0.22% | +13.5% |
| Q1 2021 | $18,390,000 | +4.0% | 81,705 | +2.6% | 0.19% | -4.0% |
| Q4 2020 | $17,682,000 | -0.0% | 79,600 | -3.1% | 0.20% | -14.8% |
| Q3 2020 | $17,683,000 | +16.4% | 82,120 | -4.4% | 0.24% | +9.8% |
| Q2 2020 | $15,191,000 | +26.0% | 85,905 | -1.4% | 0.22% | +6.4% |
| Q1 2020 | $12,061,000 | -8.7% | 87,140 | +1.2% | 0.20% | +20.2% |
| Q4 2019 | $13,217,000 | +7.0% | 86,114 | +0.7% | 0.17% | -2.3% |
| Q3 2019 | $12,352,000 | +2.9% | 85,523 | +1.8% | 0.17% | +1.2% |
| Q2 2019 | $12,005,000 | +8.7% | 83,996 | +0.4% | 0.17% | +5.6% |
| Q1 2019 | $11,049,000 | +32.4% | 83,693 | +3.4% | 0.16% | +16.7% |
| Q4 2018 | $8,343,000 | -3.4% | 80,902 | +1.7% | 0.14% | +13.1% |
| Q3 2018 | $8,640,000 | +10.5% | 79,516 | +0.4% | 0.12% | +5.2% |
| Q2 2018 | $7,816,000 | +1.7% | 79,209 | +0.9% | 0.12% | -2.5% |
| Q1 2018 | $7,689,000 | +9.0% | 78,536 | +3.4% | 0.12% | +11.2% |
| Q4 2017 | $7,052,000 | +11.0% | 75,976 | +2.6% | 0.11% | +2.9% |
| Q3 2017 | $6,351,000 | +1.1% | 74,034 | -0.5% | 0.10% | -4.6% |
| Q2 2017 | $6,280,000 | -0.8% | 74,412 | +0.5% | 0.11% | -2.7% |
| Q1 2017 | $6,332,000 | +12.2% | 74,027 | +2.2% | 0.11% | +5.7% |
| Q4 2016 | $5,641,000 | +2.0% | 72,464 | +2.7% | 0.11% | -4.5% |
| Q3 2016 | $5,529,000 | -21.6% | 70,531 | +1.1% | 0.11% | -26.0% |
| Q2 2016 | $7,048,000 | +7.4% | 69,778 | +0.9% | 0.15% | +3.4% |
| Q1 2016 | $6,563,000 | +6.4% | 69,188 | +4.1% | 0.14% | +5.1% |
| Q4 2015 | $6,171,000 | +9.2% | 66,443 | +0.2% | 0.14% | +3.0% |
| Q3 2015 | $5,651,000 | -3.4% | 66,321 | -2.9% | 0.13% | +4.7% |
| Q2 2015 | $5,847,000 | +0.6% | 68,312 | -0.2% | 0.13% | +1.6% |
| Q1 2015 | $5,813,000 | +1.6% | 68,471 | +2.6% | 0.13% | -2.3% |
| Q4 2014 | $5,721,000 | +15.6% | 66,744 | +2.5% | 0.13% | +9.3% |
| Q3 2014 | $4,948,000 | -0.9% | 65,124 | +2.7% | 0.12% | +0.9% |
| Q2 2014 | $4,994,000 | +2.3% | 63,428 | -2.6% | 0.12% | -0.8% |
| Q1 2014 | $4,884,000 | -2.0% | 65,115 | +0.9% | 0.12% | -3.3% |
| Q4 2013 | $4,983,000 | +13.3% | 64,545 | +1.7% | 0.12% | +1.7% |
| Q3 2013 | $4,398,000 | +15.3% | 63,445 | +5.3% | 0.12% | +6.2% |
| Q2 2013 | $3,815,000 | – | 60,269 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ace Management Global Ltd. | 168,488 | $42,096,727 | 12.36% |
| Zeno Equity Partners LLP | 182,612 | $45,660,122 | 12.15% |
| Defender Capital, LLC. | 135,187 | $33,776,567 | 11.54% |
| Bancreek Capital Management, LP | 56,267 | $14,058,310 | 10.98% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 214,830 | $53,664,407 | 9.84% |
| CADEN CAPITAL PARTNERS, LP | 104,501 | $26,109,575 | 9.44% |
| Dorsey Asset Management | 306,420 | $76,559,037 | 9.12% |
| Consulta Ltd | 500,000 | $124,925,000 | 8.51% |
| BOONE CAPITAL MANAGEMENT LLC | 106,360 | $26,574,046 | 6.93% |
| Manchester Global Management (UK) Ltd | 150,688 | $37,649,397 | 6.62% |